88884-2
Fatty acid omega-3 and omega-6 panel - Serum or Plasma
Active
Term Description
The terms in this panel are used to monitor the omega-3 and omega-6 levels of patients with known cardiovascular disease and who are on supplemental therapy with omega-3/omega-6 supplements or being evaluated to receive it. Early data suggests healthy levels of omega-3 and omega-6 could have positive health outcomes on patients with age-related macular degeneration, rheumatoid arthritis, cancer and others. Relative intake of omega-6s and omega-3s (omega-6/omega-3) is believed by some researchers to gauge the impact of the development of some chronic diseases including cardiovascular disease and cancer, but no ideal ratio has been determined. Similarly, no normal ranges have been defined for serum or plasma phospholipid omega 3s, reported as the percentage of total phospholipid fatty acids by weight. EPA and DHA can be measured as the percentage of total erythrocyte fatty acids and is referred to as the omega-3 index. The omega-3 index is typically 3-5% in individuals living in Western countries that have a low intake of fish in their diet. [https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/]
Source: Regenstrief LOINC
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
88884-2 | Fatty acid omega-3 and omega-6 panel - Serum or Plasma | |||
Indent88997-2 | Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C24 in Serum or Plasma | % | ||
Indent88995-6 | Docosahexaenoate (C22:6w3)/Fatty acids.C14-C24 in Serum or Plasma | % | ||
Indent88998-0 | Omega-3 (EPA+DHA) index in Serum or Plasma | % | ||
Indent88994-9 | Arachidonate (C20:4w6)/Fatty acids.C14-C24 in Serum or Plasma | % | ||
Indent88996-4 | Eicosapentaenoate (C20:5w3)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma | mol/mol | ||
Indent48382-6 | Omega 6 fatty acids (w6)/Omega 3 fatty acids (w3) [Molar ratio] in Serum or Plasma | |||
Indent88999-8 | Omega-3 (EPA+DHA) index risk in Serum or Plasma |
Fully-Specified Name
- Component
- Fatty acid omega-3 & omega-6 panel
- Property
- -
- Time
- Pt
- System
- Ser/Plas
- Scale
- -
- Method
Additional Names
- Short Name
- FA omega-3 + omega-6 panel SerPl
- Display Name
- Fatty acid omega-3 and omega-6 panel
- Consumer Name Alpha Get Info
- Fatty acid Omega-3 and Omega-6 panel, Blood
Basic Attributes
- Class
- PANEL.CHEM
- Type
- Laboratory
- First Released
- Version 2.64
- Last Updated
- Version 2.65
- Order vs. Observation
- Order
- Panel Type
- Panel
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Perfil ácidos grasos omega 3 y omega6: |
es-MX | Spanish (Mexico) | Panel de ácidos grasos omega-3 y omega-6: |
fr-FR | French (France) | Acides gras oméga-3 et oméga-6 panel: |
it-IT | Italian (Italy) | Acidi grassi omega-3 & omega-6 panel: Synonyms: Chimica Panel acidi grassi omega-3 e omega-6 Plasma Punto nel tempo (episodio) Set di prescrizione chimica Siero Siero o Plasma |
pl-PL | Polish (Poland) | Panel kwasów tłuszczowych omega-3 i omega-6: |
zh-CN | Chinese (China) | 脂肪酸 omega-3 与 omega-6 组套: Synonyms: Ⅲ III 三 化学; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=88884-2 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/88884-2
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright